Table 3.
Independent Variable | Subsequent Visual Skin Assessment (1 Week Later) | |||
---|---|---|---|---|
Unadjusted Model | Adjusted Model | |||
None Versus Erythema/Stage 1 PU | None or Erythema/Stage 1 PU Versus Stage 2+PU | None Versus Erythema/Stage 1 PU | None or Erythema/Stage 1 PU Versus Stage 2+PU | |
OR (99% Confidence Interval) | ||||
SEM | 1.003 (0.999–1.005)* | 1.003 (0.998–1.007) | 1.002 (0.999–1.005) | 1.002 (0.996–1.008) |
Subsequent SEM (1 week later) | 1.005 (1.003–1.007)* | 1.008 (1.005–1.011)* | 1.004 (1.003–1.006)* | 1.008 (1.004–1.012)* |
Anatomic location (reference = sacral) | ||||
Left buttock | 0.353 (0.159–0.785)* | (0.235 0.008–6.594) | 0.323 (0.145–0.719)* | 0.240 (0.009–6.668) |
Right buttock | 0.867 (0.421–1.785) | 2.224 (0.252–19.638) | 0.798 (0.373–1.709) | 1.916 (0.203–18.060) |
Non-Hispanic white ethnicity | 3.851 (1.254–11.831)* | 1.241 (0.100—15.387) | ||
At risk for pressure ulcers (Braden score≤18) | 2.322 (0.750–7.187) | 6.775 (0.635–72.258)* | ||
100-unit change in the SEM measure | 1.256 | 1.216 |
P ≤.05; Proportional odds models using generalized logistic regression. Odds ratios (ORs) reflect a 1-unit change in the SEM measure. Excludes observations with incontinence or Stage 2 + pressure ulcer (PU) present during initial SEM measure.